Ignite Creation Date:
2024-05-05 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00189501
Status:
COMPLETED
Last Update Posted:
2007-12-28
First Post:
2005-09-12
Brief Title:
A Multi-Center Observational Registry of Subjects With Secondary Hyperparathyroidism HPT and Chronic Kidney Disease CKD
Sponsor:
Amgen
Organization:
Amgen
Study Overview
Official Title:
A Multi-Center Observational Registry of Subjects With Secondary Hyperparathyroidism HPT and Chronic Kidney Disease CKD
Status:
COMPLETED
Status Verified Date:
2007-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Objectives include description of current practices assessment over time of KDOQI goals clinical outcomes health resource utilizationHRU and patient reported outcomes PRO and the impact of Sensipar on these parameters
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None